WHO GDP Readiness for Pharmaceutical Distribution
Accredify Global helps pharmaceutical, healthcare, and medical-product distributors build Good Distribution Practice controls for storage, transportation, traceability, and quality assurance.
We turn GDP expectations into practical distribution controls and audit evidence across warehouses, cold-chain operations, suppliers, and logistics partners.
GDP obligations depend on the product, territory, and regulator. The scope is tailored to your supply chain and applicable requirements.
What your team receives
A practical GDP readiness plan for controlled distribution and defensible quality records.
What WHO GDP readiness improves
The focus is consistent product integrity throughout the distribution chain.
Better distribution control
Clearer processes for receiving, storage, transport, returns, and recalls.
Stronger product integrity
Reduced risk from temperature excursions, contamination, mix-ups, and weak traceability.
Improved audit confidence
Quality records are easier to present to customers, regulators, and partners.
How the WHO GDP engagement works
A phased approach connects distribution risks to practical controls and evidence.
- Phase 1: Define products, facilities, routes, partners, and regulatory scope.
- Phase 2: Assess quality systems, storage, transport, records, and traceability.
- Phase 3: Prioritize corrective actions and required procedures.
- Phase 4: Support implementation, training, supplier controls, and evidence development.
- Phase 5: Run readiness review and provide a prioritized improvement report.
Distribution quality governance
Clear ownership keeps GDP controls active across quality, warehouse, logistics, and supplier teams.
Quality ownership
Define approval, deviation, and corrective-action responsibilities.
Partner oversight
Strengthen qualification and monitoring of carriers and distribution partners.
Continual review
Use deviations, complaints, and trend reviews to improve controls.
Typical WHO GDP deliverables
- GDP gap assessment and remediation tracker
- Distribution quality procedure review
- Storage, transport, and cold-chain control guidance
- Supplier and logistics-provider oversight support
- Traceability, returns, and recall readiness review
- Leadership-ready GDP readiness report
Who this is for
WHO GDP readiness is relevant where controlled product distribution affects quality, patient safety, or market access.
- Pharmaceutical distributors and wholesalers
- Healthcare and medical-product supply chains
- Cold-chain logistics and freight providers
- Importers, exporters, and warehouse operators
- Manufacturers strengthening downstream distribution controls
Explore adjacent certification and compliance links
Frequently asked questions
What is WHO GDP?
WHO Good Distribution Practice provides guidance for maintaining product quality and integrity during distribution.
Does GDP include transport controls?
Yes. Storage, transport, temperature control, traceability, and provider oversight are key parts of GDP readiness.
Can GDP align with GMP?
Yes. GMP and GDP controls can be coordinated across manufacturing and distribution quality systems.
Need a practical WHO GDP readiness plan?
We can review your distribution operations and identify the controls and evidence needed for stronger GDP compliance.
Do You Need WHO GDP Readiness Services?
You likely need this now if:
- Customers are requesting independent assurance before onboarding
- You process sensitive, regulated, or payment-related data
- You are expanding into enterprise or regulated markets
- Security questionnaires are delaying contracts
Typical Timeline
Most end-to-end compliance delivery and reporting programs take 6-12 weeks depending on scope, control maturity, and available evidence.
What Happens Next?
- We review your service model, scope, and buyer requirements
- We recommend the right compliance pathway and audit approach
- You receive a tailored proposal with timeline guidance
- We launch engagement with clear milestones and ownership
Execution Strength
Accredify Global manages end-to-end delivery, documentation, evidence operations, and audit workflow so your compliance outcome is buyer-ready.